FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q33440251> ?p ?o ?g. }

• Q33440251 description "2017 nî lūn-bûn" @default.
• Q33440251 description "2017 թուականի Մարտին հրատարակուած գիտական յօդուած" @default.
• Q33440251 description "2017 թվականի մարտին հրատարակված գիտական հոդված" @default.
• Q33440251 description "2017年の論文" @default.
• Q33440251 description "2017年論文" @default.
• Q33440251 description "2017年論文" @default.
• Q33440251 description "2017年論文" @default.
• Q33440251 description "2017年論文" @default.
• Q33440251 description "2017年論文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017年论文" @default.
• Q33440251 description "2017년 논문" @default.
• Q33440251 description "article científic" @default.
• Q33440251 description "article scientific" @default.
• Q33440251 description "article scientifique (publié 2017)" @default.
• Q33440251 description "articol științific" @default.
• Q33440251 description "articolo scientifico" @default.
• Q33440251 description "artigo científico (publicado na 2017)" @default.
• Q33440251 description "artigo científico (publicado na 2017)" @default.
• Q33440251 description "artigo científico" @default.
• Q33440251 description "artikull shkencor" @default.
• Q33440251 description "artikulong pang-agham" @default.
• Q33440251 description "artykuł naukowy" @default.
• Q33440251 description "artículo científico publicado en 2017" @default.
• Q33440251 description "artículu científicu espublizáu en 2017" @default.
• Q33440251 description "bilimsel makale" @default.
• Q33440251 description "bài báo khoa học" @default.
• Q33440251 description "mokslinis straipsnis" @default.
• Q33440251 description "naučni članak" @default.
• Q33440251 description "scienca artikolo" @default.
• Q33440251 description "scientific article" @default.
• Q33440251 description "teaduslik artikkel" @default.
• Q33440251 description "tieteellinen artikkeli" @default.
• Q33440251 description "tudományos cikk" @default.
• Q33440251 description "vedecký článok" @default.
• Q33440251 description "vetenskaplig artikel" @default.
• Q33440251 description "videnskabelig artikel (udgivet 2017)" @default.
• Q33440251 description "vitenskapelig artikkel" @default.
• Q33440251 description "vitskapeleg artikkel" @default.
• Q33440251 description "vědecký článek" @default.
• Q33440251 description "wetenschappelijk artikel" @default.
• Q33440251 description "wissenschaftlicher Artikel" @default.
• Q33440251 description "επιστημονικό άρθρο" @default.
• Q33440251 description "мақолаи илмӣ" @default.
• Q33440251 description "мақолаи илмӣ" @default.
• Q33440251 description "наукова стаття, опублікована в березні 2017" @default.
• Q33440251 description "научна статия" @default.
• Q33440251 description "научная статья" @default.
• Q33440251 description "научни чланак" @default.
• Q33440251 description "научни чланак" @default.
• Q33440251 description "מאמר מדעי" @default.
• Q33440251 description "سائنسی مضمون" @default.
• Q33440251 description "مقالة علمية" @default.
• Q33440251 description "مقالهٔ علمی" @default.
• Q33440251 description "২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q33440251 description "บทความทางวิทยาศาสตร์" @default.
• Q33440251 description "სამეცნიერო სტატია" @default.
• Q33440251 name "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 name "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 name "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 type Item @default.
• Q33440251 label "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 label "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 label "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 prefLabel "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 prefLabel "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 prefLabel "The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma" @default.
• Q33440251 P1433 Q33440251-4CC7D386-18BA-40DA-9B98-FFD9CCD49D3C @default.
• Q33440251 P1476 Q33440251-24FCF699-9FEA-4198-AA7C-DC59FA705683 @default.
• Q33440251 P2093 Q33440251-0EC20E9E-54A0-420D-8EC4-E3B303C018F3 @default.
• Q33440251 P2093 Q33440251-1C09E5BD-F40B-43A5-B272-30BDEF5510BD @default.
• Q33440251 P2093 Q33440251-2F95DD4E-D52E-461B-83A9-487CD91F762A @default.
• Q33440251 P2093 Q33440251-323E1AE8-56FE-4F15-95DD-31C79576957D @default.
• Q33440251 P2093 Q33440251-34A77F3E-7C41-4254-B069-0C418764C3E1 @default.
• Q33440251 P2093 Q33440251-37A45A72-42CC-48A1-A838-76438A54B499 @default.
• Q33440251 P2093 Q33440251-3F4B10F3-28B8-493B-A3B9-E1E657306286 @default.
• Q33440251 P2093 Q33440251-4A6A7D96-98D0-4C25-8C59-977E1796B0A5 @default.
• Q33440251 P2093 Q33440251-5B74C8A4-9B53-47F8-BFCA-B0F3BE489F32 @default.
• Q33440251 P2093 Q33440251-5E436914-6215-4F35-8657-49DEFBA8A677 @default.
• Q33440251 P2093 Q33440251-5F5A97B0-5423-4D15-A082-F67A8E98AA8B @default.
• Q33440251 P2093 Q33440251-64617F26-1166-4648-BA60-4B34802FF1C2 @default.
• Q33440251 P2093 Q33440251-64C05471-91B6-4A2F-9736-2CB18FA35AAC @default.
• Q33440251 P2093 Q33440251-7F30AA03-F09E-4221-BF73-A9D4FAAC255A @default.
• Q33440251 P2093 Q33440251-88CB751C-023A-49FA-9999-DE0C5DACD870 @default.
• Q33440251 P2093 Q33440251-99AA5A31-0002-43D0-AC6E-B93BFB608254 @default.
• Q33440251 P2093 Q33440251-C0CBCEC3-2E9B-4DA0-98F0-E504C7C12598 @default.
• Q33440251 P2093 Q33440251-CF6012D7-5213-49E8-8731-7E355DEEC367 @default.
• Q33440251 P2093 Q33440251-D89606B1-1AB0-42F2-8FE2-54956045BC47 @default.
• Q33440251 P2093 Q33440251-DB8BCACA-225C-4696-9EF8-C0F1B5831D8F @default.
• Q33440251 P2093 Q33440251-E49E2D31-22AE-45F9-A961-B1DF8D4D99EE @default.
• Q33440251 P2093 Q33440251-F167542D-4B94-43D9-B442-77811156A5C4 @default.
• Q33440251 P2093 Q33440251-F843A0EB-CEC5-443E-95C3-FA715FDD4B5E @default.
• Q33440251 P2093 Q33440251-FD84AB08-AB88-4D28-AEFB-722EFD638BA9 @default.
• Q33440251 P2860 Q33440251-0D4E0172-0209-4587-A2F9-319DC7C4461B @default.
• Q33440251 P2860 Q33440251-0F9722BE-9080-4E2D-A6EA-05DC86009023 @default.
• Q33440251 P2860 Q33440251-18D44892-D78A-4959-88E5-D36EE7488DB9 @default.

• next